Cool Developments in COPD Medicine

In this week's episode, we talk about how targeting a specific immune cell called an eosinophil may help lower the burden of COPD (chronic obstructive pilmonary disease). We explore the epidemiology, pathophysiology, and treatment options for COPD, including targeting the eosinophil pathway.References:Bhatti, M. S. (1999). A historical look at chlorofluorocarbon refrigerants. ASHRAE Transactions, 105, 1186. https://www.osti.gov/biblio/20002388Narendra, D. K., & Hanania, N. A. (2019). Targeting IL-5 in COPD. International journal of chronic obstructive pulmonary disease, 1045-1051. https://www.tandfonline.com/doi/full/10.2147/COPD.S155306World Health Organization. (6 November, 2024). Chronic obstructive pulmonary disease (COPD). [Website, accessed 4 November, 2025]. https://www.who.int/news-room/fact-sheets/detail/chronic-obstructive-pulmonary-disease-(copd)Barnes, P. J. (2019). Inflammatory endotypes in COPD. Allergy, 74(7), 1249-1256. https://onlinelibrary.wiley.com/doi/full/10.1111/all.13760Dixon F. J. (Ed.). (1987). Advances in immunology (Vol. 39). Academic Press. https://www.google.com/books/edition/Advances_in_Immunology/GXpByqkfZNcCShare with a friend. Rate, Review, and Subscribe to MedEvidence! Articles to be notified when new episodes are released.Follow us on Social Media:FacebookInstagramTwitterLinkedInTiktokYoutubeFor more great content, including discussions by physicians and clinical research experts, check out the MedEvidence! Podcast and MedEvidence.comThank you for listening!